Posted in M&A / Deals Jeito Capital secures over $1.2bn for new biopharma investments April 9, 2026 Pharmaceutical Business Review The milestone increases Jeito’s assets under management to 1.6bn, following the 534m closure of Jeito I in 2021. M&A / DealsRead full story